Unlock instant, AI-driven research and patent intelligence for your innovation.

Method of Genetically Altering and Producing Allergy Free Cats

a technology of genetic modification and cat, applied in the field of transgenic cats, can solve the problems of time involved, unappealing treatment for allergy sufferers, and high cost of regular allergy

Inactive Publication Date: 2012-06-07
AVNER DAVID B +2
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0040]FIG. 6. depicts the construction of the neor gene. The structural gene and its control elements are contained on a 1 kb cassette flanked by an XhoI site (x) and a SalI site (s) in a pUC derivative plasmid. (a) A tandem repeat of the enhancer r

Problems solved by technology

The time, effort and expense often makes this type of treatment unappealing to allergy sufferers.
Unfortunately, the expense of regular allergy shots, the time involved to receive treatment, and the variability of effectiveness are considerable deterrents for some patients.
Furthermore, there is risk that a patient may have a severe reaction to the immunization and can even go into anaphylactic shock.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of Genetically Altering and Producing Allergy Free Cats
  • Method of Genetically Altering and Producing Allergy Free Cats
  • Method of Genetically Altering and Producing Allergy Free Cats

Examples

Experimental program
Comparison scheme
Effect test

example 1

Construction of Targeting Vector

A. Homology Arms

[0268]The DNA sequence of a continuous stretch of 22182 base pairs including and surrounding chains 1 and 2 of Fel d I was isolated and identified. The promoter sequence for each chain, and found that both chains share this promoter. Chains 1 and 2 are encoded on complimentary DNA strands, and transcribed in opposite directions (FIG. 7). Additionally, sequences downstream of the 3′ end of the genes of chains 1 and 2 were identified.

[0269]The assembly of the sequence data containing Fel d I (i) chain 1, (ii) chain 2, (iii) promoter and (iv) the downstream homology arms was performed using Polymerase Chain Reaction (PCR) amplification and DNA sequencing. The published polynucleotide sequence for the Fel d I gene (Griffith et al., Gene, 113(2):263-8, 1992, and Morgenstern et al., Proc. Nat'l. Acad. Sci. USA, 88:9690, 1991), was used as a starting point for a variation of thermal asymmetric interlaced PCR (TAIL-PCR) described in Liu & Whit...

example 2

EMBRYONIC FIBROBLAST CELL LINES

[0284]Somatic cat cell lines have been established which provide a viable alternative to cat embryonic stem cells for the purpose of targeting the Fel d I gene.

A. Derivation of Cat Somatic Cell Lines-Feline Embryonic Fibroblasts FEFs

[0285]1. Fetal tissue was isolated from the uterine horns of pregnant queens by standard ovariohysterectomy between 3 and 6 weeks of gestation. Extra-embryonic membranes were dissected away from the fetal tissue.

[0286]2. Connective tissue was then isolated, minced, and incubated in a basal medium of DMEM containing 2 mg / ml collagenase and 0.25% trypsin at 37 degrees Celsius for 15 minutes with periodic agitation

[0287]3. Embryonic fibroblasts were separated from remaining undigested tissues by straining through a 50 micron cell, rinsing with PBS and concentrating by centrifugation.

B. Culture and Expansion of Feline Embryonic Fibroblasts

[0288]Primary cat somatic cells were successfully cultured, expanded and frozen following ...

example 3

Targeting of Embryonic Somatic Cell Line

[0292]Gene targeting in somatic cells has enjoyed years of successes in many different species. We use the vector described above to target Fel d 1 in the feline fibroblast cell line

A. Electroporation

[0293]Cat embryonic somatic cell lines (FEFs) are electroporated with exogenous DNA targeting constructs, as described for cat embryonic stem cells above.

B. Selection

[0294]1. Positive Selection of FEFs with Gentamicin (G418): FEF cells that retained the neomycin resistance gene (Neo) survived, when cultured in 500 micrograms of G418 per ml of ES-DMEM, 24 hours after electroporation. Whereas, FEFs without the Neo gene died within 2-7 days of culture in G418.

[0295]Negative Selection of FEFs with Ganciclovir: FEFs that retained the HSV-1 tk gene 24 hours after electroporation died within 2-7 days of subsequent culture in ES-DMEM medium containing 500 nanograms of ganciclovir. Whereas, FEF cells that lacked the HSV-1 tk gene survived culture in gancic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Digital informationaaaaaaaaaa
Digital informationaaaaaaaaaa
Digital informationaaaaaaaaaa
Login to View More

Abstract

A transgenic cat with a phenotype characterized by the substantial absence of the major cat allergen, Fel d I. The phenotype is conferred in the transgenic cat by disrupting the coding sequence of the target gene with a specialized construct. The phenotype of the transgenic cat is transmissible to its offspring.

Description

CROSS-REFERENCE TO RELATED PATENT APPLICATIONS[0001]This application is a continuation-in-part of U.S. application Ser. No. 10 / 295,903, which is a continuation application of U.S. application Ser. No. 09 / 227,873, filed on Jan. 11, 1999, which is a continuation-in-part of U.S. application Ser. No. 08 / 657,905, filed on Jun. 7, 1996, which claims priority to provisional U.S. Application Ser. No. 60 / 000,189, filed Jun. 13, 1995, wherein each application is incorporated herein in its entirety by reference.FIELD OF THE INVENTION[0002]This invention relates to the production of transgenic animals wherein a recognized gene sequence, coding for an identified allergen, is inactivated. More particularly, the invention relates to transgenic cats wherein the gene sequences, coding for the major cat allergen Fel d I, have been disrupted.BACKGROUND OF THE INVENTION[0003]Approximately 6 million Americans are allergic to cats, and although many persons allergic to cats do not have cats in their own ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/85C12N5/10C12N15/12
CPCC12N5/0603C12N2501/235C12N2510/00A01K2267/0368C12N15/873A01K2217/075A01K2227/10C12N15/8509C12N15/85C07K14/47C12N2800/30A01K67/0276C12N15/907
Inventor AVNER, DAVID B.BOCKLANDT, SVENKEHLER, JAMES
Owner AVNER DAVID B